<?xml version="1.0" encoding="UTF-8"?>
<table id="PMC7094090/table_6" xmlns="http://www.w3.org/1999/xhtml">
 <caption>
  <label>Table 6</label>
  <title>Small Molecule Compounds in Research and Development with Therapeutic Potential for COVID-19</title>
 </caption>
 <colgroup>
  <col align="left"/>
  <col align="left"/>
  <col align="left"/>
  <col align="left"/>
 </colgroup>
 <thead>
  <tr>
   <th style="border:none;" align="center" colspan="1" rowspan="1" id="0-0-.">CAS RN</th>
   <th style="border:none;" align="center" colspan="1" rowspan="1" id="0-1-.">small molecule compound</th>
   <th style="border:none;" align="center" colspan="1" rowspan="1" id="0-2-.">target</th>
   <th style="border:none;" align="center" colspan="1" rowspan="1" id="0-3-.">possible mechanism of action on COVID-19</th>
  </tr>
 </thead>
 <tbody>
  <tr>
   <td style="border:none;" align="left">4431-00-9</td>
   <td style="border:none;" align="left">aurine tricarboxylic acid</td>
   <td style="border:none;" align="left">RNA-dependent RNA polymerase (RdRp)</td>
   <td style="border:none;" align="left">an inhibitor that may bind to viral RdRp, as tested against SARS-CoV in cell culture 
    <sup>
     <a ref-type="bibr" rid="ref16">16</a>
    </sup>
   </td>
  </tr>
  <tr>
   <td style="border:none;" align="left">502960-90-9</td>
   <td style="border:none;" align="left">4-methyl- 
    <i>N</i>-[(1 
    <i>S</i>)-2-oxo-2 [[(1 
    <i>S</i>,2 
    <i>E</i>)-1-(2-phenylethyl)-3-(phenylsulfonyl)-2-propen-1-yl]amino]-1-(phenylmethyl)ethyl]- 1-piperazinecarboxamide 
   </td>
   <td style="border:none;" align="left">viral proteases: 3CLpro and PLpro</td>
   <td style="border:none;" align="left">an inhibitor that may disrupt the function of 3CLpro and PLpro, which was tested against SARS-CoV 
    <sup>
     <a ref-type="bibr" rid="ref16">16</a>, 
     <a ref-type="bibr" rid="ref39">39</a>, 
     <a ref-type="bibr" rid="ref40">40</a>
    </sup>
   </td>
  </tr>
  <tr>
   <td style="border:none;" align="left">1851279-09-8</td>
   <td style="border:none;" align="left">4-(1,1-dimethylethyl)- 
    <i>N</i>-[(1 
    <i>S</i>)-2-oxo-2-[[(1 
    <i>S</i>,2 
    <i>E</i>)-1-(2-phenylethyl)-3-(phenylsulfonyl)-2-propen-1-yl]amino]-1-(phenylmethyl)ethyl]- 1-piperazinecarboxamide 
   </td>
   <td style="border:none;" align="left"> </td>
   <td style="border:none;" align="left"> </td>
  </tr>
  <tr>
   <td style="border:none;" align="left">1851280-00-6</td>
   <td style="border:none;" align="left">4-(2-methoxyethyl)- 
    <i>N</i>-[(1 
    <i>S</i>)-2-oxo-2-[[(1 
    <i>S</i>,2 
    <i>E</i>)-1-(2-phenylethyl)-3-(phenylsulfonyl)-2-propen-1-yl]amino]-1-(phenylmethyl)ethyl]- 1-piperazinecarboxamide 
   </td>
   <td style="border:none;" align="left"> </td>
   <td style="border:none;" align="left"> </td>
  </tr>
  <tr>
   <td style="border:none;" align="left">223537-30-2</td>
   <td style="border:none;" align="left">rupintrivir</td>
   <td style="border:none;" align="left"> </td>
   <td style="border:none;" align="left">a cysteine protease inhibitor that may disrupt the function of 3CLpro and PLpro 
    <sup>
     <a ref-type="bibr" rid="ref41">41</a>
    </sup>
   </td>
  </tr>
  <tr>
   <td style="border:none;" align="left">2409054-43-7</td>
   <td style="border:none;" align="left">(α 
    <i>R</i>)-α-[[3-(4-chloro-2-fluorophenyl)-1-oxo-2-propen-1-yl]amino]- 
    <i>N</i>-[(1 
    <i>R</i>)-1-methyl-2-(2-oxo-3-pyrrolidinyl)ethyl]- benzenepropanamide 
   </td>
   <td style="border:none;" align="left">viral proteases: 3CLpro or PLpro</td>
   <td style="border:none;" align="left">an inhibitor that may disrupt the function of 3CLpro or PLpro, as tested against SARS-CoV or MERS-CoV 
    <sup>
     <a ref-type="bibr" rid="ref39">39</a>, 
     <a ref-type="bibr" rid="ref40">40</a>
    </sup>
   </td>
  </tr>
  <tr>
   <td style="border:none;" align="left">452088-38-9</td>
   <td style="border:none;" align="left">5-[(4-methyl-1-piperidinyl)sulfonyl]-1 
    <i>H</i>-indole-2,3-dione 
   </td>
   <td style="border:none;" align="left"> </td>
   <td style="border:none;" align="left"> </td>
  </tr>
  <tr>
   <td style="border:none;" align="left">2409054-44-8</td>
   <td style="border:none;" align="left">3-hydroperoxy-4-[2-hydroxy-3-[3-(4-hydroxyphenyl)-1-oxo-2-propen-1-yl]-6-methoxyphenyl]-2-butanone</td>
   <td style="border:none;" align="left"> </td>
   <td style="border:none;" align="left"> </td>
  </tr>
  <tr>
   <td style="border:none;" align="left">41137-87-5</td>
   <td style="border:none;" align="left">hirsutenone</td>
   <td style="border:none;" align="left"> </td>
   <td style="border:none;" align="left"> </td>
  </tr>
  <tr>
   <td style="border:none;" align="left">992-59-6</td>
   <td style="border:none;" align="left">benzopurpurin B</td>
   <td style="border:none;" align="left">NSP15 (poly(U)-specific endoribonuclease)</td>
   <td style="border:none;" align="left">chemical inhibitors that may suppress viral infectivity by inhibiting endoribonuclease NSP15, as tested against SARS-CoV in cultured cells 
    <sup>
     <a ref-type="bibr" rid="ref38">38</a>
    </sup>
   </td>
  </tr>
  <tr>
   <td style="border:none;" align="left">351891-58-2</td>
   <td style="border:none;" align="left">C-467929</td>
   <td style="border:none;" align="left"> </td>
   <td style="border:none;" align="left"> </td>
  </tr>
  <tr>
   <td style="border:none;" align="left">331675-78-6</td>
   <td style="border:none;" align="left">C-473872</td>
   <td style="border:none;" align="left"> </td>
   <td style="border:none;" align="left"> </td>
  </tr>
  <tr>
   <td style="border:none;" align="left">813419-93-1</td>
   <td style="border:none;" align="left">NSC-306711</td>
   <td style="border:none;" align="left"> </td>
   <td style="border:none;" align="left"> </td>
  </tr>
  <tr>
   <td style="border:none;" align="left">501444-06-0</td>
   <td style="border:none;" align="left">N-65828</td>
   <td style="border:none;" align="left"> </td>
   <td style="border:none;" align="left"> </td>
  </tr>
  <tr>
   <td style="border:none;" align="left">477775-14-7</td>
   <td style="border:none;" align="left">C-21</td>
   <td style="border:none;" align="left">AT2</td>
   <td style="border:none;" align="left">an angiotensin AT2 receptor agonist that may alleviate the virus-induced lung injury 
    <sup>
     <a ref-type="bibr" rid="ref24">24</a>
    </sup>
   </td>
  </tr>
  <tr>
   <td style="border:none;" align="left">127060-75-7</td>
   <td style="border:none;" align="left">CGP-42112A</td>
   <td style="border:none;" align="left"> </td>
   <td style="border:none;" align="left"> </td>
  </tr>
  <tr>
   <td style="border:none;" align="left">170969-73-0</td>
   <td style="border:none;" align="left">L-163491</td>
   <td style="border:none;" align="left"> </td>
   <td style="border:none;" align="left">a dual-property molecule that functions as angiotensin AT1 partial antagonist and AT2 agonist which may alleviate the virus-induced lung injury 
    <sup>
     <a ref-type="bibr" rid="ref24">24</a>
    </sup>
   </td>
  </tr>
 </tbody>
</table>
